ASH Consultative Hematology Course
The ASH Consultative Hematology Course (CHC) is an interactive, half-day program led by faculty familiar with consultative practice issues and commonly encountered clinical problems that require the expertise of a hematologist. Program participants engage in case-based presentations and discussions focusing on non-malignant hematology topics, such as thrombosis, thrombocytopenia, and bleeding.
Update your core knowledge of non-malignant hematology by attending one of two courses in 2019.
How to Register for CHC Orlando: Clinical hematologists practicing in North America may register during the online annual meeting registration process, opening now; other groups may register on site if space is available. If you would like to attend but are not planning to register for the annual meeting, contact email@example.com.
- Jenny Despotovic, DO, Texas Children’s Hospital
- Anita Rajasekhar, MD, University of Florida
Call for Cases
The American Society of Hematology invites meeting participants to submit patient case studies for the 2019 Consultative Hematology Course scheduled for September 5, 2019, at the Fairmont Chicago, Millennium Park. Selected cases will be featured in the final speaker presentations. Presentations and the subsequent panel discussion will incorporate live audience response polling questions about the cases. Case contributors will be recognized for their submission during the presentation and in the meeting mobile app.
Case Submission Categories
- Sickle Cell Disease
- Venous Thromboembolism
- Immune Thrombocytopenia
- Role of Iron Replacement Therapy Outside Classic Iron Deficiency
- Thrombotic Microangiopathy
Submission Instructions and Guidelines:
Case studies must be submitted electronically by completing the online form by July 12, 2019, 11:59 p.m. Pacific time.
Case Selection Decision: Case study contributors will be notified by July 31 if their case studies have been selected. The Consultative Hematology Course program co-chairs and speakers will serve as peer reviewers for the cases. If selected, program speakers will communicate with contributors to coordinate the case(s) to be used and the plans for incorporating the case(s) into the slide sets. Incomplete cases will not be reviewed or considered for inclusion in the final program.
back to top
- There is no fee associated with submitting a case study.
- Contributors may submit more than one case for consideration.
- Read the ASH Conflict-of-Interest Policy and submit your disclosure online at hematology.org/coi.
- When referring to drug names, please use generic names, not trade names.
- Cases must be HIPAA compliant. Any patient-identifying information must be removed prior to submission.